Mr. Mossinghoff joined G1 Therapeutics as chief business officer in 2014 and is responsible for finance, business development, planning and administration. He has more than 25 years of domestic and international pharmaceutical industry experience in big pharma and biotech in general management, corporate development, licensing, financing, strategic and new product planning, operations, market research and product valuation. Prior to G1 he served as president of Integrated Oncology Solutions and Inspire Pharmaceuticals, and helped guide Inspire from its early stages of development through its IPO and closed various corporate partnerships including those with Genentech and Allergan. In his first decade in the industry, Mr. Mossinghoff held management positions of increasing responsibility at Roche and GlaxoWellcome in global business development, product planning, finance and operations. He holds a BA in economics from the University of Virginia and an MBA in financial management and analysis from George Mason University.